Understanding a drug's mechanism of action (MoA) early in development enables precise optimization and informed decision-making across drug indications and contingency plans.
Detecting a compound’s mechanism of action early accelerates refinement of chemical structure, dosing, and target engagement, improving efficiency in preclinical and clinical stages.
Better understanding of MoA helps define the therapeutic indication, anticipate off-target effects, and develop contingency strategies for compounds with unexpected liabilities.
Profiling mitochondrial interactions and bioenergetic effects provides actionable data on compound safety, efficacy, and mechanism alignment, supporting informed decision-making across your pipeline.
What it is: Multiplexed bioenergetic profiling platform to assess mitochondrial respiration and interactions with central metabolism. Available in HTS/dose-response studies under multiple culture conditions.
What it measures :
Benefits:
What it is: Oxidative stress profiling to detect mitochondrial and cytoplasmic ROS and antioxidant responses.
What it measures (any or all):
Benefits:
What it is: High-content analysis for mtDNA quantification, mitophagy, and mitochondrial protein profiling.
What it measures:
Benefits:
All our assays are fully customizable to meet your needs.
Contact us to discuss your studyDiscover how our mitochondrial platforms support different therapeutic areas.
